OAR 333-007-0310
Definitions

For purposes of OAR 333-007-0300 (Marijuana Testing: Purpose and Effective Date) through 333-007-0500 (Quality Control and Research and Development Testing):
(1) “Added substance” means any component or ingredient added to usable marijuana, cannabinoid concentrate or cannabinoid extract during or after processing that is present in the finished cannabinoid product, including but not limited to flavors, non-marijuana derived terpenes, and any substances used to change the viscosity or consistency of the cannabinoid product.
(2) “Authority” means the Oregon Health Authority.
(3) “Batch” means:
(a) A quantity of marijuana or usable marijuana from a harvest lot; or
(b) A quantity of cannabinoid concentrate or extractor cannabinoid product from a process lot.
(4) “Cannabinoid” means any of the chemical compounds that are the active constituents of marijuana.
(5) “Cannabinoid concentrate or extract” means a substance obtained by separating cannabinoids from marijuana by a mechanical, chemical or other process.
(6) “Cannabinoid edible” means food or potable liquid into which a cannabinoid concentrate or extract or the dried leaves or flowers of marijuana have been incorporated.
(7)(a) “Cannabinoid product” means a cannabinoid edible or any other product intended for human consumption or use, including a product intended to be applied to a person’s skin or hair, that contains cannabinoids or the dried leaves or flowers of marijuana; or
(b) Usable marijuana, cannabinoid extracts and cannabinoid concentrates that have been combined with an added substance.
(c) “Cannabinoid product” does not include:
(A) Usable marijuana by itself;
(B) A cannabinoid concentrate or extract by itself; or
(C) Industrial hemp, as defined in ORS 571.300.
(8) “Cannabinoid capsule”:
(a) Means a small, soluble pill, tablet, or container that contains liquid or powdered cannabinoid product, concentrate or extract and is intended for human ingestion.
(b) Does not mean a cannabinoid suppository.
(9) “Cannabinoid suppository” means a small soluble container designed to melt at body temperature within a body cavity other than the mouth, especially the rectum or vagina containing a cannabinoid product, concentrate or extract.
(10) “Cannabinoid tincture” means a liquid cannabinoid product packaged in a container of four fluid ounces or less that consists of either:
(a) A non-potable solution of at least 25 percent non-denatured alcohol, in addition to cannabinoid concentrate, extract or usable marijuana, and perhaps other ingredients intended for human consumption or ingestion that is exempt from the Liquor Control Act under ORS 471.035 (Certain products excepted from liquor laws); or
(b) A non-potable solution comprised of glycerin, plant-based oil, or concentrated syrup; cannabinoid concentrate, extract or usable marijuana; and perhaps other ingredients that does not contain any added sweeteners and is intended for human consumption or ingestion.
(11) “Cannabinoid topical” means a cannabinoid product intended to be applied to skin or hair and for purposes of testing includes transdermal patches.
(12) “Cannabis Tracking System” or “CTS” means the Oregon Liquor Control Commission’s system for tracking the transfer of marijuana items and other information as authorized by ORS 475B.177 (Duty to develop and maintain system for tracking transfer of marijuana items).
(13) Cannabinoid Transdermal patch" means an adhesive substance applied to human skin that contains a cannabinoid product, concentrate or extract for absorption into the bloodstream.
(14) “CBD” means cannabidiol, Chemical Abstracts Service Number 13956-29-1.
(15) “CBDA” means cannabidiolic acid, Chemical Abstracts Service Number 1244-58-2.
(16) “Chain of custody procedures” means procedures employed by laboratory personnel using a chain of custody form to record the possession of samples from the time of sampling through the retention time specified by the Authority or Commission.
(17) “Chain of custody form” means a form completed by laboratory personnel that documents the collection, transport, and receipt of samples by the laboratory.
(18) “Commission” means the Oregon Liquor Control Commission.
(19) “Compliance test” means a laboratory test required by these rules in order to allow the transfer or sale of a marijuana item.
(20) “Consumer” has the meaning given that term in ORS 475B.015 (Definitions for ORS 475B.010 to 475B.545) and does not include a patient, designated primary caregiver or organization or facility caregiver.
(21) “Control study” means a study performed on products or matrices of unknown homogeneity to assure required uniformity of product accomplished through sampling and testing as described in OAR 333-007-0440 (Control Study).
(22) “Cured” means a process of removing moisture from marijuana under controlled environmental conditions so the moisture content is 15 percent or less.
(23) “Delta-9 THC” is the principal psychoactive constituent (the principal cannabinoid) of cannabis, Chemical Abstracts Service Number 1972-08-3.
(24)(a) “Designated primary caregiver” means an individual 18 years of age or older who has significant responsibility for managing the well-being of a person who has been diagnosed with a debilitating medical condition, who is designated as such on that person’s application for a registry identification card or in other written notification to the Authority, and who has been issued an identification card by the Authority under ORS 475B.415(5)(b).
(b) “Designated primary caregiver” does not include the person’s attending physician.
(25) “Field duplicate sample” means sample increments taken in an identical manner to sample increments taken for the primary sample and representative of the same marijuana item being sampled that is prepared and analyzed separately from the primary sample.
(26) “Finished cannabinoid concentrate or extract” means a cannabinoid concentrate or extract that is in its final form ready for packaging for sale or transfer to a patient, designated primary caregiver or consumer.
(27) “Finished cannabinoid product” means a cannabinoid product that is in its final form ready for packaging for sale or transfer to a patient, designated primary caregiver or consumer, and includes all ingredients whether or not the ingredients contain cannabinoids.
(28) “Food” means a raw, cooked, or processed edible substance, or ingredient used or intended for use or for sale in whole or in part for human consumption, chewing gum and includes beverages.
(29) “Grower” has the same meaning as “person responsible for a marijuana grow site.”
(30) “Grow site” means a specific location registered by the Authority and used by the grower to produce marijuana for medical use by a specific patient under ORS 475B.810 (Marijuana grow site registration system).
(31) “Harvest lot” means a specifically identified quantity of marijuana that is cultivated utilizing the same growing practices, harvested within a 72-hour period at the same location and cured under uniform conditions.
(32) “High heat” means a temperature exceeding 180 degrees Fahrenheit.
(33) “Homogeneous” means a cannabinoid product, concentrate or extract has uniform composition and properties throughout each process lot.
(34) “Human consumption or human ingestion” means to ingest, generally through the mouth, food, drink or other substances such that the substance enters the human body but does not include inhalation.
(35) “Human use” includes human consumption or human ingestion, inhalation, topical application or any other use that allows a cannabinoid to enter the human body.
(36) “Laboratory” means a laboratory that is accredited under ORS 438.605 (Definitions for ORS 438.605 to 438.620, 448.280 and 448.285) to 438.620 (Accreditation fees) to sample or conduct tests on marijuana items and licensed by the Oregon Liquor Control Commission under ORS 475B.560 (Laboratory licensure).
(37) “Level of quantification” means the minimum levels, concentrations, or quantities of a target variable, for example an analyte, that can be reported by a laboratory with a specified degree of confidence.
(38) “Licensee” has the meaning given that term in ORS 475B.015 (Definitions for ORS 475B.010 to 475B.545).
(39)(a) “Marijuana” means the plant Cannabis family Cannabaceae, any part of the plant Cannabis family Cannabaceae and the seeds of the plant Cannabis family Cannabaceae.
(b) “Marijuana” does not include industrial hemp, as defined in ORS 571.300.
(40) “Marijuana item” means marijuana, usable marijuana, a cannabinoid product or a cannabinoid concentrate or extract.
(41) “Marijuana processing site” means a marijuana processing site registered under ORS 475B.840 (Marijuana processing site registration system).
(42) “Medical marijuana dispensary” or “dispensary” means a medical marijuana dispensary registered under ORS 475B.858 (Medical marijuana dispensary registration system).
(43) “ORELAP” means the Oregon Environmental Laboratory Accreditation Program administered by the Authority pursuant to ORS 438.605 (Definitions for ORS 438.605 to 438.620, 448.280 and 448.285) to 438.620 (Accreditation fees).
(44) “Organization or facility caregiver” means:
(a) An organization that provides hospice, palliative or home health care services that:
(A) Is licensed under ORS 443.014 (Definitions for ORS 443.014 to 443.105) to 443.105 (Caregiver registries), 443.305 (Definitions for ORS 443.305 to 443.350) to 443.355 (Complaint procedures), or 443.850 (Definitions for ORS 443.850 to 443.869) to 443.869 (Civil penalties);
(B) Has significant responsibility for managing the well-being of a patient; and
(C) Is designated by the Authority as an additional caregiver for a patient; or
(b) A residential facility as defined in ORS 443.400 (Definitions for ORS 443.400 to 443.455) that:
(A) Is licensed under ORS 443.400 (Definitions for ORS 443.400 to 443.455) to 443.455 (Civil penalties);
(B) Has significant responsibility for managing the well-being of a patient: and
(C) Is designated by the Authority as an additional caregiver for a patient.
(45) “Patient” has the same meaning as “registry identification cardholder.”
(46) “Person responsible for a marijuana grow site” has the same meaning as “grower” and means a person who has been selected by a patient to produce medical marijuana for the patient and who has been registered by the Authority for this purpose under ORS 475B.810 (Marijuana grow site registration system).
(47) “Process lot” means:
(a) Any amount of cannabinoid concentrate or extract of the same type and processed using the same extraction methods, standard operating procedures and batches from the same or a different harvest lot; or
(b) Any amount of a cannabinoid product of the same type and processed using the same ingredients, standard operating procedures and batches from the same or a different harvest lot or process lot of cannabinoid concentrate or extract.
(48) “Processing” means the compounding or conversion of marijuana into cannabinoid products, or cannabinoid concentrates or extracts.
(49) “Processing site” means a processor registered with Authority under ORS 475B.840 (Marijuana processing site registration system).
(50) “Processor” has the meaning given that term in OAR 845-025-1015 (Definitions).
(51) “Producer” has the meaning given that term in OAR 845-025-1015 (Definitions).
(52) “Producing” means:
(a) Planting, cultivating, growing, trimming or harvesting marijuana; or
(b) Drying marijuana leaves and flowers.
(53) “Registrant” means a grower, marijuana processing site, or a medical marijuana dispensary registered with the Authority under ORS 475B.810 (Marijuana grow site registration system), 475B.840 (Marijuana processing site registration system) or 475B.858 (Medical marijuana dispensary registration system).
(54) “Registry identification cardholder” means a person who has been diagnosed by an attending physician with a debilitating medical condition and for whom the use of medical marijuana may mitigate the symptoms or effects of the person’s debilitating medical condition, and who has been issued a registry identification card by the Authority under ORS 475B.797 (Registry identification cardholders)(5)(a).
(55) “Relative percentage difference” or “RPD” means the comparison of two quantities while taking into account the size of what is being compared as calculated under OAR 333-064-0100 (Marijuana Item Sampling Procedures and Testing).
(56) “Relative standard deviation” or “RSD” means the standard deviation expressed as a percentage of the mean recovery as calculated under OAR 333-064-0100 (Marijuana Item Sampling Procedures and Testing).
(57) “Remediation”:
(a) Means a process or technique applied to a marijuana item to remove pesticides or solvents.
(b) Does not include dilution.
(58) “Sample” means an amount of a marijuana item collected by laboratory personnel from a registrant or licensee and provided to a laboratory for testing.
(59) “Sample increment” means an amount of a marijuana item collected by laboratory personnel from a registrant or licensee that may be combined into a sample for purposes of testing or, in the case of a control study, is tested individually.
(60) “Standard operating procedure” for the purposes of producing kief includes but is not limited to procedures for creating the kief, purging unwanted components from the kief, thoroughly cleaning all equipment, counters and surfaces used to produce the kief, and appropriate use of any necessary safety or sanitary equipment.
(61) “Sterilization” means the removal of all microorganisms and other pathogens from a marijuana item by treating it with approved chemicals or subjecting it to high heat.
(62) “Test batch” means a group of samples from a batch submitted collectively to a laboratory for testing purposes.
(63) “Texture” means the feel, appearance, or consistency of a marijuana item.
(64) “THC” means tetrahydrocannabinol and has the same Chemical Abstracts Service Number as delta-9 THC.
(65) “THCA” means tetrahydrocannabinolic acid, Chemical Abstracts Service Number 23978-85-0.
(66) “These rules” means OAR 333-007-0300 (Marijuana Testing: Purpose and Effective Date) through 333-007-0500 (Quality Control and Research and Development Testing).
(67) “Total THC” means the molar sum of THC and THCA.
(68) “Unit of sale” means an amount of a marijuana item commonly packaged for transfer or sale to a consumer, patient, designated primary caregiver or organization or facility caregiver, or capable of being packaged for transfer or sale to a consumer, patient, designated primary caregiver or organization or facility caregiver.
(69) “Usable marijuana”:
(a) Means the dried leaves and flowers of marijuana.
(b) Includes, for purposes of these rules, pre-rolled marijuana as long as the pre-roll consists of only dried marijuana leaves and flowers, an unflavored rolling paper and a filter or tip.
(c) Does not include:
(A) The seeds, stalks and roots of marijuana; or
(B) Waste material that is a by-product of producing or processing marijuana.

Source: Rule 333-007-0310 — Definitions, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=333-007-0310.

Last Updated

Jun. 8, 2021

Rule 333-007-0310’s source at or​.us